{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:16:38Z","timestamp":1781777798068,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Health Research (DHR), Ministry of Health and Family Welfare (MOHFW), Government of India."},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["CTU\/PM-ABHIM\/17\/10\/33\/2023-ECD-II"],"award-info":[{"award-number":["CTU\/PM-ABHIM\/17\/10\/33\/2023-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70161-8","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:45:32Z","timestamp":1724406332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel metric-based approach of scoring early host immune response from oro-nasopharyngeal swabs predicts COVID-19 outcome"],"prefix":"10.1038","volume":"14","author":[{"given":"Yogita","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Neral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Sherwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaylakshmi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malti","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulsay","family":"Paikra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeramani","family":"Lodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omprakash","family":"Sundrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masood A.","family":"Shammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannath","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"10223","key":"70161_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395(10223), 497\u2013506 (2020).","journal-title":"The Lancet"},{"issue":"5","key":"70161_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan, Q. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46(5), 846\u2013848 (2020).","journal-title":"Intensive Care Med."},{"issue":"1","key":"70161_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target Ther. 6(1), 255 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"70161_CR4","doi-asserted-by":"publisher","first-page":"e300849","DOI":"10.1371\/journal.pbio.3000849","volume":"18","author":"NAP Lieberman","year":"2020","unstructured":"Lieberman, N. A. P. et al. In vivo antiviral host response to SARS-CoV-2by viral load, sex, and age. PLoS Biol. 18, e300849 (2020).","journal-title":"PLoS Biol."},{"key":"70161_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jmv.25770","volume":"92","author":"Y Gao","year":"2020","unstructured":"Gao, Y. et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol. 92, 791\u2013796 (2020).","journal-title":"J. Med. Virol."},{"issue":"1","key":"70161_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12864-021-07433-4","volume":"22","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets. BMC Genom. 22(1), 125 (2021).","journal-title":"BMC Genom."},{"issue":"6","key":"70161_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin, A. et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182(6), 1401-1418.e18 (2020).","journal-title":"Cell"},{"issue":"1","key":"70161_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/s41598-022-05968-4","volume":"12","author":"E Cervantes-Alvarez","year":"2022","unstructured":"Cervantes-Alvarez, E. et al. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2infected patients. Sci. Rep. 12(1), 1856 (2022).","journal-title":"Sci. Rep."},{"key":"70161_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103525","volume":"70","author":"A Biji","year":"2021","unstructured":"Biji, A. et al. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. EBioMedicine 70, 103525 (2021).","journal-title":"EBioMedicine"},{"issue":"18","key":"70161_CR10","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","volume":"184","author":"CGK Ziegler","year":"2021","unstructured":"Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2infection in severe COVID-19. Cell 184(18), 4713\u20134733 (2021).","journal-title":"Cell"},{"key":"70161_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ijid.2020.10.003","volume":"101","author":"C Nagant","year":"2020","unstructured":"Nagant, C. et al. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int. J. Infect. Dis. 101, 342\u2013345 (2020).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"70161_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41421-021-00289-8","volume":"7","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease. Cell Discov. 7(1), 48 (2021).","journal-title":"Cell Discov."},{"key":"70161_CR13","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1038\/s41598-024-63184-8","volume":"14","author":"K Uno","year":"2024","unstructured":"Uno, K. et al. Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts. Sci. Rep. 14, 12713. https:\/\/doi.org\/10.1038\/s41598-024-63184-8 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"70161_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00011-021-01516-4","volume":"71","author":"L Garc\u00eda de Guadiana-Romualdo","year":"2022","unstructured":"Garc\u00eda de Guadiana-Romualdo, L. et al. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: A multicenter, prospective study (CalCov study). Inflamm. Res. 71(1), 57\u201367 (2022).","journal-title":"Inflamm. Res."},{"key":"70161_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider, W. M. et al. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513\u201345 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"70161_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605024","volume":"11","author":"E Yang","year":"2020","unstructured":"Yang, E. & Li, M. M. H. All About the RNA: Interferon-stimulated genes that interfere with viral RNA processes. Front. Immunol. 11, 605024 (2020).","journal-title":"Front. Immunol."},{"issue":"4","key":"70161_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1534","volume":"10","author":"SL Schwartz","year":"2019","unstructured":"Schwartz, S. L. & Conn, G. L. RNA regulation of the antiviral protein 2\u2019-5\u2019-oligoadenylate synthetase. Wiley Interdiscip. Rev. RNA 10(4), e1534 (2019).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"70161_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore, K. W. et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683\u2013765 (2001).","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"70161_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M. & O\u2019Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10(3), 170\u2013181 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"70161_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.1998.tb08314.x","volume":"856","author":"LR Leon","year":"1998","unstructured":"Leon, L. R. et al. Role of IL-10 in inflammation Studies using cytokine knockout mice. Ann. N. Y. Acad. Sci. 856, 69\u201375 (1998).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"70161_CR21","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","volume":"66","author":"RK Sellon","year":"1998","unstructured":"Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66(11), 5224\u20135231 (1998).","journal-title":"Infect. Immun."},{"issue":"2","key":"70161_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R K\u00fchn","year":"1993","unstructured":"K\u00fchn, R. et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75(2), 263\u2013274 (1993).","journal-title":"Cell"},{"issue":"4","key":"70161_CR23","first-page":"129","volume":"31","author":"TH Ng","year":"2013","unstructured":"Ng, T. H. et al. Regulation of adaptive immunity; the role of interleukin-10. Front. Immunol. 31(4), 129 (2013).","journal-title":"Front. Immunol."},{"issue":"3","key":"70161_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005493","volume":"12","author":"SS Cush","year":"2016","unstructured":"Cush, S. S. et al. Locally produced IL-10 limits cutaneous vaccinia virus spread. PLoS Pathog. 12(3), e1005493 (2016).","journal-title":"PLoS Pathog."},{"key":"70161_CR25","doi-asserted-by":"publisher","first-page":"11066","DOI":"10.1177\/11772719221106600","volume":"17","author":"S Jafrin","year":"2022","unstructured":"Jafrin, S. et al. Elevated levels of pleiotropic interleukin-6 (IL-6) and interleukin-10 (IL-10) are critically involved with the severity and mortality of COVID-19: An updated longitudinal meta-analysis and systematic review on 147 studies. Biomark. Insights 17, 11066 (2022).","journal-title":"Biomark. Insights"},{"issue":"2","key":"70161_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06155","volume":"7","author":"SK Dhar","year":"2021","unstructured":"Dhar, S. K. et al. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 7(2), e06155 (2021).","journal-title":"Heliyon"},{"issue":"6","key":"70161_CR27","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34(6), 108728 (2021).","journal-title":"Cell Rep."},{"issue":"4","key":"70161_CR28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"CR Moderbacher","year":"2020","unstructured":"Moderbacher, C. R. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183(4), 996-1012.e19 (2020).","journal-title":"Cell"},{"issue":"22","key":"70161_CR29","doi-asserted-by":"publisher","first-page":"13951","DOI":"10.3390\/ijms232213951","volume":"23","author":"I V\u00e1lyi-Nagy","year":"2022","unstructured":"V\u00e1lyi-Nagy, I. et al. Adaptive immunity to viruses: What did we learn from SARS-CoV-2 infection?. Int. J. Mol. Sci. 23(22), 13951 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"71","key":"70161_CR30","doi-asserted-by":"publisher","first-page":"eabo1303","DOI":"10.1126\/sciimmunol.abo1303","volume":"7","author":"S Vardhana","year":"2022","unstructured":"Vardhana, S., Baldo, L., Morice, W. G. 2nd. & Wherry, E. J. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci. Immunol. 7(71), eabo1303. https:\/\/doi.org\/10.1126\/sciimmunol.abo1303 (2022).","journal-title":"Sci. Immunol."},{"key":"70161_CR31","first-page":"1","volume":"149","author":"D Kamimura","year":"2003","unstructured":"Kamimura, D. et al. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149, 1\u201338 (2003).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"6","key":"70161_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","volume":"63","author":"M Ahmadi","year":"2017","unstructured":"Ahmadi, M. et al. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment. Syst. Biol. Reprod. Med. 63(6), 350\u2013359 (2017).","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"7","key":"70161_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33057","volume":"31","author":"MJ Moore","year":"2018","unstructured":"Moore, M. J. et al. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity. Elife 31(7), e33057 (2018).","journal-title":"Elife"},{"issue":"4","key":"70161_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy, M. J. et al. The IL-17 family of cytokines in health and disease. Immunity. 50(4), 892\u2013906 (2019).","journal-title":"Immunity."},{"issue":"3","key":"70161_CR35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/CCM.0000000000001409","volume":"44","author":"C Mikacenic","year":"2016","unstructured":"Mikacenic, C. et al. Interleukin-17A is associated with alveolar inflammation and poor outcomes in acute respiratory distress syndrome. Crit. Care Med. 44(3), 496\u2013502 (2016).","journal-title":"Crit. Care Med."},{"issue":"6","key":"70161_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n, D. & S\u00e1nchez-Madrid, F. CD69: from activation marker to metabolic gatekeeper. Eur. J. Immunol. 47(6), 946\u2013953 (2017).","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"70161_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1084\/jem.178.2.537","volume":"178","author":"M L\u00f3pez-Cabrera","year":"1993","unstructured":"L\u00f3pez-Cabrera, M. et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM\/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178(2), 537\u2013547 (1993).","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"70161_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jim.2004.07.006","volume":"293","author":"M Reddy","year":"2004","unstructured":"Reddy, M. et al. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J. Immunol. Methods 293(1\u20132), 127\u2013142 (2004).","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"70161_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0090-1229(90)90012-F","volume":"54","author":"AL Jackson","year":"1990","unstructured":"Jackson, A. L. et al. Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells. Clin. Immunol. Immunopathol. 54(1), 126\u2013133 (1990).","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"3","key":"70161_CR40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0952-7915(00)00096-0","volume":"12","author":"JJ Campbell","year":"2000","unstructured":"Campbell, J. J. & Butcher, E. C. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12(3), 336\u2013341 (2000).","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"70161_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1073\/pnas.95.1.258","volume":"95","author":"MD Gunn","year":"1998","unstructured":"Gunn, M. D. et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 95(1), 258\u2013263 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70161_CR42","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V","volume":"29","author":"F Sallusto","year":"1999","unstructured":"Sallusto, F. et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29, 2037\u20132045 (1999).","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"70161_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/cancers14061436","volume":"14","author":"E Tibbs","year":"2022","unstructured":"Tibbs, E. & Cao, X. Emerging canonical and non-canonical roles of granzyme B in health and disease. Cancers (Basel) 14(6), 1436 (2022).","journal-title":"Cancers (Basel)"},{"issue":"6","key":"70161_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z. et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20(6), 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"70161_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan, I. et al. Breadth of concomitant immune responses prior to patient recovery: A case report of non-severe COVID-19. Nat. Med. 26, 453\u2013455 (2020).","journal-title":"Nat. Med."},{"issue":"12","key":"70161_CR46","doi-asserted-by":"publisher","first-page":"e1010211","DOI":"10.1371\/journal.ppat.1010211","volume":"17","author":"P Almendro-Vazquez","year":"2021","unstructured":"Almendro-Vazquez, P. et al. Longitudinal dynamics of sars-Cov-2-Specific cellular and humoral immunity after natural infection or Bnt162b2 vaccination. PLoS Pathog. 17(12), e1010211. https:\/\/doi.org\/10.1371\/journal.ppat.1010211 (2021).","journal-title":"PLoS Pathog."},{"issue":"12","key":"70161_CR47","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/eji.202048908","volume":"50","author":"AE Oja","year":"2020","unstructured":"Oja, A. E. et al. Divergent sars-Cov-2-Specific T- and b-cell responses in severe but not mild covid-19 patients. Eur. J. Immunol. 50(12), 1998\u20132012. https:\/\/doi.org\/10.1002\/eji.202048908 (2020).","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"70161_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/cid\/civ951","volume":"62","author":"VM Corman","year":"2016","unstructured":"Corman, V. M. et al. Viral shedding and antibody response in 37 patients with middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62(4), 477\u2013483. https:\/\/doi.org\/10.1093\/cid\/civ951 (2016).","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"70161_CR49","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3201\/eid2112.151421","volume":"21","author":"WB Park","year":"2015","unstructured":"Park, W. B. et al. Kinetics of serologic responses to mers coronavirus infection in humans, south Korea. Emerg. Infect. Dis. 21(12), 2186\u20132189. https:\/\/doi.org\/10.3201\/eid2112.151421 (2015).","journal-title":"Emerg. Infect. Dis."},{"issue":"12","key":"70161_CR50","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/eji.201646548","volume":"46","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection. Eur. J. Immunol. 46(12), 2778\u20132788 (2016).","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"70161_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nm.1929","volume":"15","author":"J Sun","year":"2009","unstructured":"Sun, J. et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15(3), 277\u2013284 (2009).","journal-title":"Nat. Med."},{"issue":"2","key":"70161_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.virol.2010.05.004","volume":"404","author":"EM Palmer","year":"2010","unstructured":"Palmer, E. M. et al. IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology 404(2), 225\u2013230 (2010).","journal-title":"Virology"},{"key":"70161_CR53","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fphar.2020.01093","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Dynamic interleukin-6 level changes as a prognostic indicator in patients with COVID-19. Front. Pharmacol. 11, 1093 (2020).","journal-title":"Front. Pharmacol."},{"issue":"47","key":"70161_CR54","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","volume":"105","author":"T Korn","year":"2008","unstructured":"Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105(47), 18460\u201318465 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"70161_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","volume":"36","author":"ERA-EDTA Council; ERACODA Working Group","year":"2021","unstructured":"ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol. Dial. Transplant. 36(1), 87\u201394 (2021).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"70161_CR56","first-page":"50","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris, S. et al. The role of inflammation in diabetes: Current concepts and future perspectives. EurCardiology 14(1), 50\u201359 (2019).","journal-title":"EurCardiology"},{"key":"70161_CR57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","volume":"19","author":"MP David","year":"2021","unstructured":"David, M. P. et al. The role of inflammation in hypertension: novel concept. Curr. Opin. Physiol. 19, 92\u201398 (2021).","journal-title":"Curr. Opin. Physiol."},{"issue":"2018","key":"70161_CR58","first-page":"2180373","volume":"6","author":"S Mihai","year":"2018","unstructured":"Mihai, S. et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J. Immunol. Res. 6(2018), 2180373 (2018).","journal-title":"J. Immunol. Res."},{"issue":"6","key":"70161_CR59","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon, K. C. et al. Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am. J. Clin. Nutr. 83(6), 1345\u201350 (2006).","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"70161_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","volume":"127","author":"J McGovern","year":"2022","unstructured":"McGovern, J. et al. Cancer cachexia: a nutritional or a systemic inflammatory syndrome?. Br. J. Cancer 127(3), 379\u2013382 (2022).","journal-title":"Br. J. Cancer"},{"issue":"8","key":"70161_CR61","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-018-4091-5","volume":"37","author":"J Hurnakova","year":"2018","unstructured":"Hurnakova, J. et al. Serum calprotectin may refectinfammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Clin. Rheumatol. 37(8), 2055\u20132062 (2018).","journal-title":"Clin. Rheumatol."},{"issue":"21","key":"70161_CR62","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.3390\/ijms21218075","volume":"21","author":"MM Oosterwijk","year":"2020","unstructured":"Oosterwijk, M. M. et al. Determinants of increased serum calprotectin in patients with type 2 diabetes mellitus. Int. J. Mol. Sci. 21(21), 8075 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"70161_CR63","unstructured":"Sergeant, ESG, 2018. Epitools Epidemiological Calculators. Ausvet. http:\/\/epitools.ausvet.com.au."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70161-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:55:18Z","timestamp":1724406918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70161"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70161-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3930462\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JP and YR have a pending patent application to Indian Patent office. Application number: 202321017746; Title: \u201cAn invitro method and a kit for determining the severity of COVID-19 outcome\u201d. Other authors do not have any competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19510"}}